BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, Navar AM, Gulati M, Johnson H, Baum S, Michos ED. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2021;10:e019636. [PMID: 33719496 DOI: 10.1161/JAHA.120.019636] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
Number Citing Articles
1 Kianoush S, Rifai MA, Patel J, Michos ED, Alam M, Samad Z, Sohail R, Cader FA, Sayed A, Zhu D, Virani SS. Racial disparity in flu vaccine uptake among Asian American Individuals: A National Health Interview Survey Study. Curr Probl Cardiol 2022;:101391. [PMID: 36100094 DOI: 10.1016/j.cpcardiol.2022.101391] [Reference Citation Analysis]
2 Tu Q, Hyun K, Hafiz N, Knight A, Hespe C, Chow CK, Briffa T, Gallagher R, Reid CM, Hare DL, Zwar N, Woodward M, Jan S, Atkins ER, Laba T, Halcomb E, Usherwood T, Billot L, Redfern J. Age-Related Variation in the Provision of Primary Care Services and Medication Prescriptions for Patients with Cardiovascular Disease. IJERPH 2022;19:10761. [DOI: 10.3390/ijerph191710761] [Reference Citation Analysis]
3 Okoli GN, Reddy VK, Lam OLT, Racovitan F, Al-Yousif Y, Askin N. Characteristics and methodological standards across systematic reviews with Meta-analysis of efficacy and/or effectiveness of influenza vaccines: an overview of reviews. Infect Dis (Lond) 2022;:1-20. [PMID: 36000220 DOI: 10.1080/23744235.2022.2114537] [Reference Citation Analysis]
4 Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. The Lancet 2022;400:693-706. [DOI: 10.1016/s0140-6736(22)00982-5] [Reference Citation Analysis]
5 Mohamed H, Karim A, Hani J, Wissam K, Ayman E. Influenza vaccine among patients with coronary artery disease. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.07.018] [Reference Citation Analysis]
6 Maniar YM, Al-Abdouh A, Michos ED. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis. Curr Cardiol Rep 2022. [PMID: 35876953 DOI: 10.1007/s11886-022-01748-8] [Reference Citation Analysis]
7 Lapi F, Marconi E, Gualano MR, Vetrano DL, Grattagliano I, Rossi A, Cricelli C. A Cohort Study on Influenza Vaccine and All-Cause Mortality in Older Adults: Methodological Concerns and Public Health Implications. Drugs Aging 2022. [PMID: 35867212 DOI: 10.1007/s40266-022-00958-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Candeloro M, Schulman S. Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis. Semin Thromb Hemost 2022. [PMID: 35793687 DOI: 10.1055/s-0042-1749661] [Reference Citation Analysis]
9 Liu R, Patel A, Du X, Liu H, Liu B, Wang C, Di Tanna GL. Association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis. BMJ Open 2022;12:e054171. [PMID: 35361644 DOI: 10.1136/bmjopen-2021-054171] [Reference Citation Analysis]
10 Diaz-Arocutipa C, Saucedo-Chinchay J, Mamas MA, Vicent L. Influenza vaccine improves cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Travel Med Infect Dis 2022;:102311. [PMID: 35339690 DOI: 10.1016/j.tmaid.2022.102311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Pankayatselvan V, Mukamal KJ. Influenza vaccination among adults with cardiovascular disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019. Am Heart J 2022;244:50-3. [PMID: 34599883 DOI: 10.1016/j.ahj.2021.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Behrouzi B, Udell JA. Universal flu vaccines: a shot at lifelong cardioprotection? Nat Rev Cardiol 2022. [PMID: 35027698 DOI: 10.1038/s41569-021-00670-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S46-59. [PMID: 34964869 DOI: 10.2337/dc22-S004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
14 Fallani E, Orsi A, Signori A, Icardi G, Domnich A. An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderly. Hum Vaccin Immunother 2021;:1-8. [PMID: 34965179 DOI: 10.1080/21645515.2021.2005381] [Reference Citation Analysis]
15 Malacara-Villaseñor A, Ilaraza-Lomeli H, Tapia-Conyer R, Sarti E. Influenza and morbidity and mortality risk in patients in Mexico with systemic arterial hypertension alone or with comorbidities: a retrospective, observational, cross-sectional study from 2014 to 2020. BMJ Open 2021;11:e057225. [PMID: 34921092 DOI: 10.1136/bmjopen-2021-057225] [Reference Citation Analysis]
16 Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Beckman JA, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Dagogo-Jack S, de Boer IH, DeFronzo RA, Eckel RH, Einhorn D, Fonseca VA, Green JB, Grunberger G, Guerin C, Inzucchi SE, Jellinger PS, Kosiborod MN, Kushner P, Lepor N, Mende CW, Michos ED, Plutzky J, Taub PR, Umpierrez GE, Vaduganathan M, Weir MR. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications 2021;:108101. [PMID: 34922811 DOI: 10.1016/j.jdiacomp.2021.108101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Duffy E, Chilazi M, Cainzos-Achirica M, Michos ED. Cardiovascular Disease Prevention During the COVID-19 Pandemic: Lessons Learned and Future Opportunities. Methodist Debakey Cardiovasc J 2021;17:68-78. [PMID: 34824683 DOI: 10.14797/mdcvj.210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Chen CC, Lin CH, Hao WR, Yeh JS, Chiang KH, Fang YA, Chiu CC, Yang TY, Wu YW, Liu JC. Influenza Vaccination and the Risk of Ventricular Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease: A Population-Based Longitudinal Study. Front Cardiovasc Med 2021;8:731844. [PMID: 34722665 DOI: 10.3389/fcvm.2021.731844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Michos ED, Udell JA. Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death. Circulation 2021;144:1485-8. [PMID: 34723637 DOI: 10.1161/CIRCULATIONAHA.121.057534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Orchard JW, Orchard JJ, Puranik R. 'Stay home when sick' advice: implications for sport and exercise. BMJ Open Sport Exerc Med 2021;7:e001227. [PMID: 34712490 DOI: 10.1136/bmjsem-2021-001227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Behrouzi B, Udell JA. Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination. Curr Atheroscler Rep 2021;23:78. [PMID: 34671861 DOI: 10.1007/s11883-021-00973-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chang HC, Liu SF, Li YC, Kuo HC, Tsai YC, Chen MH. The Effectiveness of Influenza Vaccination on Chronic Obstructive Pulmonary Disease with Different Severities of Airflow Obstruction. Biomedicines 2021;9:1175. [PMID: 34572361 DOI: 10.3390/biomedicines9091175] [Reference Citation Analysis]
23 Rohde D, Nahrendorf M. Bad company: monocytes in HIV and atherosclerosis. Cardiovasc Res 2021;117:993-4. [PMID: 33693568 DOI: 10.1093/cvr/cvab058] [Reference Citation Analysis]
24 Liprandi ÁS, Liprandi MIS, Zaidel EJ, Aisenberg GM, Baranchuk A, Barbosa ECD, Sánchez GB, Alexander B, Zanetti FTL, Santi RL, Múnera-Echeverri AG, Perel P, Piskorz D, Ruiz-Mori CE, Saucedo J, Valdez O, Juanatey JRG, Piñeiro DJ, Pinto FJ, Quintana FSW. Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart 2021;16:55. [PMID: 34381676 DOI: 10.5334/gh.1069] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, Navar AM, Gulati M, Johnson H, Baum S, Michos ED. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2021;10:e019636. [PMID: 33719496 DOI: 10.1161/JAHA.120.019636] [Cited by in F6Publishing: 26] [Reference Citation Analysis]